ReviewHerz2026
[Telemedicine in heart failure : Evidence, benefits and future perspectives].
Review in Herz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years telemonitoring for heart failure (TmHi) has transitioned from project-based pilot applications to a structured and fully reimbursed component of routine outpatient care in Germany. This development is supported by robust evidence from randomized controlled trials and meta-analyses demonstrating consistent reductions in mortality and hospitalizations, improved treatment adherence and enhanced continuity of care. Both noninvasive and implant-based monitoring strategies enable early detection of pathophysiological deterioration and facilitate proactive therapeutic adjustments through telemedicine centers (TMZ) in close collaboration with primary physicians. The implementation of TmHi in Germany relies on clear legal, technical and organizational standards, although current practice across centers remains heterogeneous and reveals potential for improvement in workflow standardization, interoperability, staffing and reimbursement management. In addition to the proven clinical benefits, in the context of the demographic changes TmHi is gaining in importance economically and in the healthcare system. Telemonitoring is thus poised to evolve from a specialized adjunct service into a cornerstone of predictive, digitally integrated care of heart failure.
Indexed as
Identifiers
41569319What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.